Goldenwell Biotech, Inc. (GWLL): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$46.0K
As of 2022-12-31
-42.9%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $46.0K | -78.5% | 2023-04-13, Balance as of period end |
| 2021-12-31 | $213.6K | -14.1% | 2023-04-13, Balance as of period end |
| 2020-12-31 | $248.6K | +0.8% | 2023-02-06, Balance as of period end |
| 2019-12-31 | $246.6K | n/a | 2021-07-23, Balance as of period end |